Introduction
In the UK, angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor antagonists are currently the first-line recommendation for treatment of hypertension in primary care in patients under 55 years of age, and second-line recommendation for all patients requiring combination therapy. 1 Angioedema is well known to occur with antihypertensive drugs, particularly ACE inhibitors and angiotensin II receptor antagonists. Angioedema is oedema that occurs in the skin and mucous membranes, often presenting as facial swelling, which may progress to swelling of the tongue, pharynx and larynx resulting in airway compromise. 2 The incidence of angioedema in patients taking ACE inhibitors is 0.1-0.7%. 3 There has been significant morbidity and mortality 4 associated with ACE inhibitor angioedema. The incidence of patients requiring a surgical airway was 80% in one case series. 5 The authors in that series acknowledged that tracheostomy might not have been necessary in all cases.
There are previous case series discussing the presentation and management of patients with ACE inhibitor-associated angioedema, reported from emergency departments and allergy clinics, but very little addressing those presenting to critical care. We were only able to find one case series specifically addressing the critical care population, which included five patients. 5 Other case series did not describe the Cormack and Lehane grade at laryngoscopy. Our aims were to describe the incidence, presentation, management and outcome of patients presenting with ACE inhibitor or angiotensin II receptor antagonist angioedema to a large intensive care unit (ICU) over 11 years, with a view to making recommendations as to how future management can best be guided in critical care.
Methods
Ethics approval was sought from the South East Scotland Research Ethics Service, who concluded that formal ethics review was not necessary. We conducted a retrospective chart review at the ICU of the Royal Infirmary of Edinburgh, an 870-bedded teaching hospital. Using the ICU database (WardWatcher TM ) all patients with a diagnostic category of anaphylaxis and upper airway obstruction, admitted between 1st January 1999 and 1st November 2010 were identified. ICU discharge letters for all patients were reviewed and case notes retrieved for any patient in whom ACE inhibitor-or angiotensin II receptor antagonist-precipitated angioedema was possible.
For all patients with ACE inhibitor (or angiotensin II receptor antagonist)-precipitated angioedema, the case notes were reviewed. Data on patient demographics, precipitant drug, clinical presentation, medical management and airway management were collected, as was data pertaining to ICU length of stay, hospital length of stay and mortality. In those patients who required advanced airway management, the method of induction of anaesthesia and the Cormack and Lehane grade at laryngoscopy was recorded.
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Original articles Results
Ninety-two patients were identified from the WardWatcher database with a diagnosis of upper airway obstruction or anaphylaxis. Review of ICU discharge letters and case notes identified 16 patients with a diagnosis of ACE inhibitor or angiotensin II receptor angioedema. Nine patients were female and seven were male, with a mean age of 69 years.
The clinical presentation of the 16 patients with ACE inhibitor or angiotensin II receptor angioedema is summarised in Table 1 . All patients had tongue swelling, 11 of 16 (69%) had respiratory symptoms or signs and eight of 16 (50%) had difficulty swallowing secretions. Three patients presented in respiratory arrest, two of whom also had a cardiac arrest. Fourteen patients were referred to critical care from the emergency department, one from the medical admissions' unit and one was referred from the coronary care unit.
The precipitant drugs are summarised in Table 2 . Fifteen of 16 (94%) episodes were precipitated by an ACE inhibitor, with an angiotensin II receptor antagonist being implicated in one patient.
All patients received adrenaline, chlorphenamine and hydrocortisone as part of their initial management. Only three of the 16 (19%) patients received IV adrenaline, with 10 of 16 (62.5%) receiving intramuscular adrenaline and 10 of 16 (62.5%) receiving nebulised adrenaline.
In this group, five of 16 (31%) patients required tracheal intubation. Three of these patients received IV drugs to facilitate tracheal intubation, one had an inhalational induction and one patient had an awake fibreoptic intubation. The patients who had IV drugs to facilitate tracheal intubation were Cormack and Lehane grades one, two and four respectively.
The patient who had an inhalational induction had a grade two laryngoscopy.
Fifteen of the 16 patients (94%) survived to hospital discharge; one patient died following a five-day ICU stay from a pulmonary embolus. The median length of stay in critical care was 0.8 days (interquartile range 0.5-3 days [range 0.2-35.7 days]). The median hospital stay was 3.5 days (interquartile range 1-9 days [range 0.2-54 days]). Five (31.25%) patients were discharged home directly from critical care, with 11 (69%) transferred to a medical ward prior to hospital discharge.
Discussion
ACE inhibitors are increasingly prescribed for hypertension and left ventricular systolic dysfunction. The exact mechanism of ACE inhibitor angioedema is yet to be elucidated, although the accumulation of bradykinin resulting in vasodilatation is likely to be important. 2 It is unknown why some patients are susceptible. The results shown here highlight that not all patients presenting with ACE inhibitor angioedema require tracheal intubation, with only 31% requiring intubation in this series. The outcome was good, with only one death, which was not directly due to angioedema. As in previous case series, there were more females than males presenting with ACE inhibitor angioedema, although this was not statistically significant.
All of the patients in this case series received adrenaline, chlorphenamine and hydrocortisone. In non-mast cellmediated angioedema, such as ACE inhibitor angioedema, the roles of adrenaline, chlorphenamine and steroids are not clear. Due to difficulties in differentiating allergic from non-allergic angioedema in the emergency setting, most previous case series and reviews have supported their use. 2, 3, 6 Only three patients received IV adrenaline. This may have been due to concerns of precipitating myocardial ischaemia in a population with risk factors for coronary artery disease.
Two patients in this case series suffered cardiopulmonary arrest as a result of their angioedema. One of these presented to the emergency department in respiratory arrest but rapidly deteriorated to cardiac arrest. They were successfully resuscitated, had a three-day ICU stay, and were discharged from hospital to their own homes. The other patient who suffered cardiopulmonary arrest as a result of their angioedema had initially presented with tongue and facial swelling, which improved with initial management in the emergency department. They were then discharged to the medical Original articles assessment unit. Following transfer, angioedema rapidly recurred and the patient deteriorated to cardiopulmonary arrest. This resulted in a prolonged intensive care admission during which the patient developed multiple organ failure. The ICU length of stay was 35 days, with a total hospital stay of 54 days, and it is this isolated case that accounts for the large range in ICU and hospital stay. One patient in our series died in the ICU on day five from pulmonary embolus. The patient had presented in respiratory arrest but also had significant co-morbidities, with colorectal carcinoma and hypertension. At the time of the arrest, there were some laryngeal reflexes present and anaesthetic drugs were required to facilitate tracheal intubation. This was difficult, with a Cormack and Lehane grade four laryngoscopy.
Only one of the five patients in our study who were intubated had an awake fibreoptic intubation. Three of the others were intubated while in, or shortly following, respiratory arrest, where the urgency of the situation would have precluded fibreoptic intubation. All had some laryngeal reflexes and required IV drugs to facilitate tracheal intubation. The final patient had an inhalational induction, with a Cormack and Lehane grade two laryngoscopy. All patients were successfully intubated, with none requiring a surgical airway.
Airway management in the case of ACE inhibitor angioedema presents significant challenges. Intravenous induction of anaesthesia carries the risk of creating an apnoeic patient in whom an airway cannot be secured; inhalational induction is not always easy in an hypoxaemic, agitated patient with impaired gas exchange; awake fibreoptic intubation can precipitate complete airway occlusion and again may be impossible in an agitated patient who is hypoxaemic or hypercarbic; and surgical access to the airway may be hindered by anterior neck swelling.
The recent NAP4 report 7 has highlighted that airway management in the emergency department is a particular area of concern, with recommendations summarised as having the "right person, right place, right equipment, right preparation." In the situation of ACE inhibitor-associated angioedema it is very difficult to be prescriptive as to what method should be used to secure the airway when this is necessary. Previous authors have recommended awake fibreoptic intubation in all patients. 8 This is clearly not always necessary and may be impossible in an agitated, hypoxaemic, hypercarbic patient.
Classical teaching would recommend an inhalational induction in cases of partial airway obstruction, with efforts made to keep the patient breathing spontaneously where possible. This technique may not be possible if airway obstruction is almost complete, and the amount of gas exchange occurring is very low. In some cases where the airway needs to be secured imminently, IV drugs may be the preferred option for allowing the best attempt at tracheal intubation. When an ENT surgeon is immediately available, tracheostomy under local anaesthesia can be considered.
While the method used to secure the airway may vary depending on the patient' s presentation and the skills of the attending doctor, patients with ACE inhibitor angioedema are best managed by collaboration between specialists in emergency medicine, anaesthesia, intensive care medicine and ENT surgery. There must be a clear plan in place to establish a surgical airway in the case of failed intubation and the precipitation of a "can't intubate, can't ventilate" situation. Lessons learnt from this case series include the fact that some patients presenting with ACE inhibitor angioedema can be successfully intubated with the use of an IV drug-assisted intubation. We would also recommend that following discharge from the emergency department, this group of patients are best observed in a critical care area.
